Acadian Asset Management’s Precision BioSciences DTIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $948K | Sell |
225,937
-22,683
| -9% | -$95.2K | ﹤0.01% | 992 |
|
|
2025
Q1 | $1.18M | Hold |
248,620
| – | – | ﹤0.01% | 888 |
|
|
2024
Q4 | $946K | Buy |
248,620
+98,440
| +66% | +$375K | ﹤0.01% | 938 |
|
|
2024
Q3 | $1.35M | Buy |
150,180
+39,407
| +36% | +$353K | ﹤0.01% | 858 |
|
|
2024
Q2 | $1.08M | Sell |
110,773
-3,499
| -3% | -$34K | ﹤0.01% | 969 |
|
|
2024
Q1 | $1.55M | Buy |
114,272
+2,808
| +3% | +$38K | 0.01% | 725 |
|
|
2023
Q4 | $1.22M | Buy |
111,464
+6,523
| +6% | +$71.4K | ﹤0.01% | 804 |
|
|
2023
Q3 | $1.07M | Buy |
104,941
+8,080
| +8% | +$82.6K | ﹤0.01% | 840 |
|
|
2023
Q2 | $1.53M | Hold |
96,861
| – | – | 0.01% | 771 |
|
|
2023
Q1 | $2.19M | Buy |
96,861
+7,278
| +8% | +$164K | 0.01% | 681 |
|
|
2022
Q4 | $3.2M | Buy |
89,583
+13,167
| +17% | +$470K | 0.02% | 558 |
|
|
2022
Q3 | $2.98M | Buy |
76,416
+1,641
| +2% | +$64K | 0.02% | 528 |
|
|
2022
Q2 | $3.59M | Buy |
74,775
+41,210
| +123% | +$1.98M | 0.02% | 490 |
|
|
2022
Q1 | $3.1M | Buy |
33,565
+20,647
| +160% | +$1.91M | 0.01% | 565 |
|
|
2021
Q4 | $2.87M | Buy |
12,918
+8,134
| +170% | +$1.81M | 0.01% | 574 |
|
|
2021
Q3 | $1.66M | Buy |
4,784
+3,405
| +247% | +$1.18M | 0.01% | 727 |
|
|
2021
Q2 | $517K | Buy |
+1,379
| New | +$517K | ﹤0.01% | 1141 |
|
|
2020
Q2 | – | Sell |
-774
| Closed | -$140K | – | 2249 |
|
|
2020
Q1 | $140K | Buy |
+774
| New | +$140K | ﹤0.01% | 1278 |
|